Streetbeat News

Revenues

GENI

Genius Sports projects its Q1 revenue to be $117M and anticipates its full-year 2024 revenue to reach $480M.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 12:03 pm

EVGO

EVgo projects its FY24 total revenue to be in the range of $220M-$270M, which is below the estimated $260.86M.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 12:02 pm

CDNS

Analyst ratings for Cadence Design Systems (NASDAQ:CDNS) show a mix of bullish to bearish sentiments, with recent updates indicating a positive trend. The average 12-month price target has risen to $323.56, reflecting a 9.96% increase from the previous target. Cadence's financial performance is strong, with significant revenue growth, high net margin, and efficient asset management. The company's market position is robust, benefiting from the digitalization of various end markets.

Portfolio Pulse from Benzinga Insights

March 06, 2024 | 12:00 pm

MOH

Five analysts have recently updated their ratings on Molina Healthcare (NYSE:MOH), showing a mix of opinions. The average 12-month price target for MOH has been raised to $420.6, indicating a 10.25% increase from the previous target. Analysts from Barclays, Truist Securities, Wells Fargo, Cantor Fitzgerald, and UBS have adjusted their price targets and ratings, reflecting changes in market conditions and company performance. Molina Healthcare's financials show strong revenue growth, net margin, ROE, and ROA, but a high debt-to-equity ratio poses a challenge.

Portfolio Pulse from Benzinga Insights

March 06, 2024 | 12:00 pm

ROK

Recent analysis of Rockwell Automation (NYSE:ROK) by 9 analysts shows a mix of bullish and bearish sentiments, with a negative shift in the average 12-month price target by 3.97% to $306.89. Analysts from firms like Berenberg, JP Morgan, and Citigroup have adjusted their ratings and price targets, reflecting changes in market dynamics and company performance. Rockwell Automation, a leader in automation, shows strong financial health with notable revenue growth, net margin, ROE, and ROA, despite challenges in debt management.

Portfolio Pulse from Benzinga Insights

March 06, 2024 | 12:00 pm

HON

Honeywell Intl (NASDAQ:HON) has received varied analyst ratings over the past three months, with a recent shift towards a more bullish outlook. The latest average price target is $223.0, marking a 7.04% increase from the previous target. Analysts from Berenberg, Barclays, RBC Capital, and Wells Fargo have updated their ratings and price targets, reflecting changes in market conditions and company performance. Honeywell, a global conglomerate, has shown notable revenue growth and profitability, with a strong financial overview including a high net margin and ROE.

Portfolio Pulse from Benzinga Insights

March 06, 2024 | 12:00 pm

CNC

Six financial analysts have recently updated their ratings on Centene (NYSE:CNC), with a mix of bullish, somewhat bullish, and indifferent perspectives. The average 12-month price target for CNC is now $88.00, up from $78.60, indicating an 11.96% increase. Analysts from Barclays, Wells Fargo, Truist Securities, UBS, and Cantor Fitzgerald have adjusted their ratings and price targets, reflecting optimism about Centene's market performance. Centene, a managed-care organization, has shown strong financial indicators such as revenue growth, net margin, ROE, and ROA, outperforming industry averages. However, its debt-to-equity ratio is higher than the industry average, suggesting financial risk.

Portfolio Pulse from Benzinga Insights

March 06, 2024 | 12:00 pm

UNFI

United Natural Foods (UNFI) has updated its fiscal year 2024 guidance, narrowing its adjusted EPS range from $(0.88)-$0.38 to $(0.56)-$0.06, which is below the $0.04 estimate. Sales guidance was also narrowed from $30.90B-$31.50B to $30.50B-$31.00B, compared to a $31.01B estimate. The company adjusted its net loss and EBITDA projections, indicating a slightly improved but still challenging financial outlook.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 12:00 pm

EVC

Entravision shares are trading lower following Meta's decision to terminate its ASP program globally by July 1, impacting all ASPs including Entravision. This program constituted a significant part of Entravision's total consolidated revenue.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 11:51 am

NEUE

NeueHealth projects its FY24 enterprise revenue to reach $1 billion, with an expected enterprise adjusted EBITDA ranging between $15 million and $25 million.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 11:50 am